LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period; Revenue in the Americas decreased 28.9%, and revenue in Asia/Pacific & Europe decreased 7.7%; Net income per diluted share was $0.11, versus $0.26 per diluted share a year ago; Adjusted earnings per diluted share was $0.12, compared to $0.26 a year ago; and Adjusted EBITDA was $3.2 million compared to $6.4 million a year ago.